| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Total revenues [+] | 4.4 | 2.2 | 1.0 | 0.1 | 0.1 | 0.0 |
| Products | | | 0.9 | 0.1 | 0.0 | |
| Revenue growth | 101.5% | 120.3% | 939.9% | -25.2% | | |
| Cost of goods sold | 17.1 | 8.3 | 2.9 | 0.1 | 0.1 | 0.0 |
| Gross profit | -12.8 | -6.1 | -1.9 | 0.0 | 0.0 | 0.0 |
| Gross margin | -291.0% | -279.1% | -194.7% | -34.2% | 38.2% | |
| Selling, general and administrative [+] | 19.9 | 8.3 | 6.5 | 7.2 | 1.9 | 0.9 |
| Sales and marketing | 7.0 | 2.2 | 1.0 | 1.6 | 0.8 | 0.5 |
| General and administrative | 12.9 | 6.1 | 5.5 | 5.6 | 1.1 | 0.5 |
| Research and development | | | 6.0 | 3.8 | 1.5 | 1.0 |
| EBITDA [+] | -30.4 | -13.5 | -13.7 | -10.6 | -3.3 | -1.9 |
| EBITDA growth | 125.3% | -2.0% | 30.1% | 222.7% | 72.4% | |
| EBITDA margin | -692.2% | -619.1% | -1391.4% | -11123.9% | -2577.9% | |
| Depreciation and amortization | 2.3 | 0.9 | 0.7 | 0.5 | 0.0 | 0.0 |
| EBIT [+] | -32.7 | -14.4 | -14.5 | -11.0 | -3.3 | -1.9 |
| EBIT growth | 127.1% | -0.3% | 31.2% | 234.6% | 72.8% | |
| EBIT margin | -745.8% | -661.9% | -1463.3% | -11602.4% | -2593.7% | |
| Non-recurring items [+] | 18.9 | 3.0 | | | | |
| Asset impairment | 6.8 | | | | | |
| In-process research & development | 12.1 | 3.0 | | | | |
| Interest expense, net [+] | -0.2 | -0.7 | 0.9 | 0.1 | 0.0 | 0.0 |
| Interest expense | | | 0.9 | 0.1 | 0.0 | 0.0 |
| Interest income | 0.2 | 0.7 | | | | |
| Other income (expense), net [+] | 3.9 | -1.4 | 0.0 | 0.1 | 0.0 | 0.0 |
| Gain (loss) on foreign currency transactions | | 0.0 | | | | |
| Other non-operating income | | | | | | 0.0 |
| Pre-tax income | -47.6 | -18.1 | -15.3 | -11.1 | -3.3 | -1.9 |
| Income taxes | 2.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -50.5 | -18.1 | -15.3 | -11.1 | -3.3 | -1.9 |
| Net margin | -1151.3% | -832.6% | -1553.0% | -11633.1% | -2610.2% | |
| |
| Basic EPS [+] | ($1.38) | ($0.63) | ($0.85) | ($0.70) | ($0.24) | ($0.19) |
| Growth | 117.0% | -25.1% | 20.6% | 186.8% | 27.0% | |
| Diluted EPS [+] | ($1.38) | ($0.63) | ($0.85) | ($0.70) | ($0.24) | ($0.19) |
| Growth | 117.0% | -25.1% | 20.6% | 186.8% | 27.0% | |
| |
| Shares outstanding (basic) [+] | 36.7 | 28.6 | 18.1 | 15.8 | 13.6 | 10.0 |
| Growth | 28.4% | 57.6% | 15.1% | 16.2% | 36.0% | |
| Shares outstanding (diluted) [+] | 36.7 | 28.6 | 18.1 | 15.8 | 13.6 | 10.0 |
| Growth | 28.4% | 57.6% | 15.1% | 16.2% | 36.0% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |